Thus, the increased gene expression of FAS and FASL may be a determining factor for the severity of COVID-19, as it is likely that they trigger the death of T cells and thus lead to the development of lymphopenia present in patients with severe COVID-19. The gene discussed is FAS; the disease is COVID-19.